Your browser doesn't support javascript.
loading
Primary drug resistance to both rifampicin and dapsone in a paucibacillary leprosy patient.
Indian J Lepr ; 1988 Jan; 60(1): 90-2
Article in English | IMSEAR | ID: sea-55423
ABSTRACT
A thirty-one year old male patient was diagnosed and treated for a pure or better primary neuritic case of leprosy with dapsone (100 mg daily for 2 years) and rifampicin (600 mg daily for 6 months). From the very outset, the patient did not show any improvement; on the top of it, he subsequently, developed a cutaneous patch, which on histopathological examination, revealed classical features of BT leprosy. Acid-fast bacilli were absent both in skin slit smear and histologic section. A primary resistance to both dapsone and rifampicin, even in paucibacillary patient, is speculated.
Subject(s)
Full text: Available Index: IMSEAR (South-East Asia) Main subject: Rifampin / Humans / Male / Drug Resistance, Microbial / Leprosy, Tuberculoid / Adult / Dapsone / Drug Therapy, Combination / Mycobacterium leprae Language: English Journal: Indian J Lepr Journal subject: Tropical Medicine Year: 1988 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: IMSEAR (South-East Asia) Main subject: Rifampin / Humans / Male / Drug Resistance, Microbial / Leprosy, Tuberculoid / Adult / Dapsone / Drug Therapy, Combination / Mycobacterium leprae Language: English Journal: Indian J Lepr Journal subject: Tropical Medicine Year: 1988 Type: Article